Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism SMOC2 modulators(SPARC related modular calcium binding 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Mediar Therapeutics, Inc.Startup |
Active Organization Mediar Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | US | Mediar Therapeutics, Inc.Startup | 23 Jun 2024 |